Michael P Mullen, MD
- PROFESSOR | Medicine, Infectious Diseases
- DIRECTOR INSTITUTE FOR ADVANCED MEDICINE
In the NewsDr. Mullen talks about the ongoing struggle against AIDS, treatment improvements, and new drugs in e Daily News feature "The Daily Check Up."
View the PDF.
American Board of Internal Medicine
- HIV And AIDS
MD, Universidad de Navarra
Residency, Internal Medicine, Interfaith Medical Center
Fellowship, Infectious Disease, Cabrini Medical Center [CLOSED]
- A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
The purpose of this research study is to see if an investigational combination medication Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen (E/C/F/TAF STR) is safe and effective in reducing levels of HIV-1 in the blood of subjects who are treatm...